Skip to main content
OpenTrials

Clinical trial condition

Meningococcal Disease

Explore clinical trials studying Meningococcal Disease. Study availability and eligibility vary by location and protocol.

57 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Meningococcal Disease trial results

Completed

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

NCT01682876

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site Lake Mary, Florida, United States
  • GSK Investigational Site Marietta, Georgia, United States
View all 19 locations
View Trial Details
Completed

Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents According to Different Vaccination Schedules

NCT00661713

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Site 13: Liceo Diego Aracena de Lo Barnechea Monseñor Escrivá de Balaguer 14630, Lo Barnechea, Santiago Metropolitan, Chile
  • Site 41: Colegio Antonio Hermida Fabres Av. Coronel Alejandro Sepúlveda N° 6801, Chile
  • Site 43: Liceo José Victorino Lastarria Av. Miguel Claro N° 32, Chile
  • Site 51: Centro Para vacunas en Desarrollo. Hospital de Niños Roberto del Rio Av. Prof Zañartu 1085, Chile
View Trial Details
Completed

Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life

NCT01214837

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
Locations
  • Birmingham, Alabama, United States
  • Fayetteville, Arkansas, United States
  • Jonesboro, Arkansas, United States
  • Little Rock, Arkansas, United States
View all 40 locations
View Trial Details
Completed

Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine

NCT01027351

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital Oxford, United Kingdom
View Trial Details
Completed

Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of Age

NCT00329849

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • FUNCEI, French 3085 Buenos Aires, Argentina
  • Centro di Desarrollo de Proyectos Avanzados (CEDEPAP) Roma 1464 Córdoba, Argentina
  • Hospital de Pediatria "Sor Maria Ludovica", Calle 14 N1631,(1900) La Plata, Argentina
View Trial Details
Completed

Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents

NCT02285777

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Melbourne, Florida, United States
  • GSK Investigational Site Newton, Kansas, United States
View Trial Details
Completed

Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea

NCT01766206

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Ansan, South Korea
  • GSK Investigational Site Anyang, South Korea
  • GSK Investigational Site Bucheon-si, South Korea
  • GSK Investigational Site Busan, South Korea
View all 54 locations
View Trial Details
Completed

Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents

NCT02140762

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Accelovance, Inc Huntsville, Alabama, United States
  • The Children's Clinic of Jonesboro, P.A. Jonesboro, Arkansas, United States
  • Accelovance, Inc Melbourne, Florida, United States
  • Heartland Research Associates LLC Newton, Kansas, United States
View Trial Details
Completed

Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine or Meningococcal C Conjugate Vaccine

NCT01345721

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • Dr. Johannes Kandzora and Dr. Kathrin Kandzora Am Teich 11, Neumuenster, Germany
  • Bogda-Maria Kniese, Boyneburgstr 7, Eschwege, Germany
  • Dr Goertz Martin Kimmig GroBbottwarer Str 47, Oberstenfeld, Germany
  • Dr med Walter Otto Heinrichstrasse 16 A, Fulda, Germany
View Trial Details

Related conditions